K L Nichol. Show Affiliations »
Abstract
Mesh: See more » AdultCost-Benefit AnalysisEmploymentHumansInfluenza Vaccines/economicsInfluenza, Human/economicsInfluenza, Human/epidemiologyInfluenza, Human/prevention & controlMiddle AgedSick Leave/economicsUnited StatesVaccination/economics
Substances: See more » Influenza Vaccines
Year: 2001 PMID: 11176832
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272